官方服务：
资源简介：
COVID-19 drug combinations in clinical trials
应用场景：
创建时间：
2020-09-14
相关数据集
Additional file 2 of Standard of care for COVID-19 in randomized clinical trials registered in trial registries and published in preprint servers and scholarly journals: a cross-sectional study
Additional file 2 Supplementary file 2. Raw data from clinical trial registries (Available at Open Science Framework: https://osf.io/he9c8/ )
DataCite Commons2022-06-19 更新120
Supplementary material: COVID-19 clinical trials: who is likely to participate and why?
These are peer-reviewed supplementary materials for the article 'COVID-19 clinical trials: who is likely to participate and why?' published in the Journal of Comparative Effectiveness Research.Appendi
becaris.figshare.com2024-07-24 更新60
COVID19 - Clinical Trials
The objective of the project is to extract a set of clinical trials carried out for Covid-19 disease around the world in order to carry out statistical and data mining studies . The ClinicalTria
NIAID Data Ecosystem40
Chemopreventive effect of α-hederin/carboplatin combination against experimental colon hyperplasia and impact on JNK signaling
Colon cancer is the commonest cancer worldwide. α-Hederin is a monodesmosidic triterpenoid saponin possessing diverse pharmacological activities. The running experiment was designed to test the chemop
DataCite Commons2021-05-08 更新80
Rationale and design of the “Tocilizumab in patients with moderate to severe COVID-19: an open-label multicentre randomized controlled” trial (TOCIBRAS)
ABSTRACT Introduction: Pro-inflammatory markers play a significant role in the disease severity of patients with COVID-19. Thus, anti-inflammatory therapies are attractive agents for potentially com
NIAID Data Ecosystem50
